“…Procoagulation and the varying effects of anticoagulation are the major focal points of this thesis. Procoagulant toxins can be simplified into four groups: prothrombin activators (Bos and Camire, 2010;Joseph and Kini, 2002;Kini, 2005a;Kornalik and Blombäck, 1975;Pirkle et al, 1972;Rogalski et al, 2017;Rosing and Tans, 1992;Yamada et al, 1996), Factor X activators (Chen et al, 2008;Joseph and Kini, 2002;Oulion et al, 2018;Tans and Rosing, 2002;Yamada et al, 1997), Factor V activators (Bos and Camire, 2010;Bos et al, 2016;Rosing et al, 2001;Williams et al, 1994;Zdenek et al, 2019), and thrombin-like enzymes (Cho et al, 2001;Esnouf and Tunnah, 1967;Huang et al, 2011;Lin et al, 2009;Nielsen, 2016b;Teng, 1976, 1978;Pradniwat and Rojnuckarin, 2015;Tan, 2010;Tan et al, 2012;Zhang et al, 2007), while anticoagulants can affect any number of factors singularly or synergistically, such as blocking clotting enzymes while activating Protein C (Bakker et al, 1993;Esmon et al, 1987;Jin and Gopinath, 2016;Kisiel et al, 1987;Kogan et al, 1993;Nakagaki et al, 1990). These types of activators or inhibitors have been found and isolated from a number of varying families and species of venomous snakes.…”